Meeting
2021 Genitourinary Cancers Symposium
Imaging modality and frequency in surveillance of stage I seminoma testicular cancer: Results from a randomized, phase III, factorial trial (TRISST).
Presenter
Johnathan K. Joffe, MD, MBBS, FRCP
Huddersfield Royal Infirmary
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Oral Abstract Session
Session Title
Oral Abstract Session: Urothelial Carcinoma; and Adrenal, Penile, Testicular, and Urethral Cancers
Track
Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Imaging
Clinical Trial Registration Number
NCT00589537
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 374)
DOI
10.1200/JCO.2021.39.6_suppl.374
Abstract #
374
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2024 ASCO Genitourinary Cancers Symposium
Evaluating prognostic models for stage I seminoma within the randomised trial of imaging and surveillance in seminoma testis (TRISST).
Speaker: Robert A Huddart, PhD, MBBS, FRCR, MRCP
Videos & Slides
2023 ASCO Genitourinary Cancers Symposium
European Association of Urology (EAU) Testicular Cancer Guidelines Panel: A new prognostic factor risk group classification for patients with clinical stage 1 seminoma in active surveillance.
Speaker: Robert James Hamilton, MD, MPH
Videos & Slides
2023 ASCO Genitourinary Cancers Symposium
Comparative cost-effectiveness of alternative imaging and surveillance schedules for testicular seminoma in the TRISST trial.
Speaker: Robert A Huddart, MBBS, FRCR, MRCP, PhD
Speaker: Panel Discussion